A cross-sectional study reported that albumin-based inflammatory indices, particularly the unscaled fibrinogen-to-albumin ratio, independently correlate with and predict systemic lupus erythematosus (SLE) disease activity. The work positions routinely available lab values as potential tools for tracking inflammatory burden. Because SLE activity measurement is clinically sensitive to timing and treatment changes, having scalable markers can support monitoring in real-world practice and in research settings where standardized activity tracking is needed. The findings add to efforts to improve biomarker practicality without sacrificing performance, especially when SLE patients require frequent reassessment. Next steps for the field include prospective longitudinal validation across diverse patient populations and mapping performance against established indices during flare and response periods.